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The hepatic stimulatory substance (HSS) extracted from weanling rat livers was purified 
381.000-/0Id using chromatographic techniques including nondissociatillg polyacrylamide 
gel electrophoresis (nondenaturing PAGE). The activity of this highly purified HSS. 
named Acr-F4 • was assessed ill tll'O in vivo models. III 40% hepatectomized rats, it 
produced a fi\'efold increase in the proliferati\'e rate lIormal/y seen following this partial 
hepatectomy. III Ed fistula dogs. the level of hase illcrease in hepatocyte renewal was 
amplified threefold by a.'! injllSion of Acr-F4 (50 ng/kg/day). Acr-F4 had no influellce on the 
regenerative response of the kidney following a unilateral nephrectomy or of the bowel 
following a 40% resection of the smal/ bOll'el. On the basis of these findings. it can be 
concluded that HSS (Acr-F4) has a high biological activity and is organ specific. 
KEY WORDS: hepatic sllmulatory substance; pUrification; gel electrophoresis. 
That liver regeneration could be augmented by 
extracts prepared from livers in an active prolifer-
ative state has been demonstrated by several inves-
tigators (\-4). However. all attempts focused on 
purification and characterization of the putative 
growth factor in these extracts have produced few 
and generally inconclusive results. A partially puri-
fied factor. hepatic stimulatory substance (HSS). 
capable of stimulating in vivo hepatocyte prolifera-
tion (5. 6) has been isolated from weanling rat liver 
homogenates. 
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In this paper. data concerning further purification 
and characterization of HSS is reported, made 
possible by the use of new laboratory techniques 
and the introduction of a very sensitive and reliable 
animal model for assessing HSS activity ill vivo. 
Specifically, nondissociating polyacrylamide gel 
electrophoresis allowed us to obtain a 381.000-fold 
purification of HSS. eliminating almost all contam-
inating proteins in the preparation. In addition. the 
dog with a portacaval shunt coupled with the avail-
ability of specific antibodies against HSS made it 
possible to achieve this level of purification. 
MATERIALS AND METHODS 
Chemicals and Materials. Type· V neuraminidase. tryp· 
sin. aprotmin. and protems used as molecular weight 
markers were purchased from Sigma Chemical Company. 
SI. Louis. MissourI. [lIIerlry/·'HIThymldine (50-80 Cif 
mmo!) was obtained from New England Nuclear. Boston. 
Massachusetts. l·l· Tosylamtdo·2·phenylethyl chlorome· 
thyltrYPsln ketone was purchased from Worthington Bio· 
chemtcal Corporation. Boston. Massachusetts. Amicon 
ultrafiltration membrane filters were purchased from Am· 
icon Corporation. Danvers. Massachusetts. The chemi· 
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FIg I. Portacaval shunt model in dogs. 
Pump 
cals required for electrophoresis were purchased from 
Bio-Rad Laboratories. Richmond. California. 
Animals. Adult male Fischer (F344) rats 080-200 g), 
weanling male rats (60-90 g), and male mongrel dogs 
(15-20 kg) were purchased from Hilltop Lab Animals. 
Scottsdale. Pennsylvania. They were maintained in tem-
perature- and light- (6 AM to 6 PM) controlled rooms until 
used. They were given food and water ad libitum. 
Surgical Procedures. Adult rats underwent either a 40% 
hepatectomy or a sham operation consisting of a laparot-
omy and manual manipulation of the liver between 7:30 
and 9:30 AM using the method of Higgins and Anderson 
(7). Unilateral nephrectomy and 40% resections of the 
small bowel were performed as described previously (8). 
In dogs, large side-to-side portacaval shunts were con-
structed with an excision of an ellipse of tissue from both 
the portal vein and the inferior vena cava and anastomos-
ing the two vessels side to side (Figure I). The shunts 
were made completely diverting by individually ligating 
the main right and Icrt portal trunks distal to the anasto-
mosis of the portal vein to the IVC (9). The tip of a small 
infusion catheter was placed into the ligated left portal 
branch within the liver and led through the body wall and 
via a long subcutaneous tunnel to a small calibrated finger 
pump that was placed into a dog jacket (Figure I). 
HSS Preparation and Purification. The steps for HSS 
preparation and purification are summarized in Table I. 
These methods (6) yielded an active fraction that has been 
identified as Flso because it elutes from the column with 
alSO mM NaCl gradient. 
Nondissociating PAGE. An aliquot of 0.6 mg lyophilized 
fraction F lso resuspended in Tris butTer 0.025 M. pH 8.3, 
underwent electrophoresis using nondissociating PAGE 
(10. II) on 8% acrylamide. With this technique. cf~o 
generates several distinct bands, and the gel can be 
divided in four zones from which its proteins can be 
eluted. The eluates, acrylamide fractions 1-4 (Acr FI-F .. ) 
are dialyzed against 150 mM ammonium acetate, lyo-
philized. and stored at -700 C until being tested further. 
In Vivo Determination of Activity of HSS and Its Frac-
tions. In rats. 6 hr after a 40% partial hepatectomy, 
control rats were given intraperitoneal injections of 2 ml 
of 5 mM phosphate butTer. pH 7.4. whereas HSS-treated 
rats received either Flso or an acrylamide fraction dis-
solved in 2 ml phosphate buffer. 5 mM. pH 7.4. at the 
protein concentrations indicated in the tables. Seventeen 
hours later. 50 Il-Ci [3HJthymidine were injected intraperi-
toneally, and the animals were sacrificed I hr later. Six 
hours after surgery. the rats that had received a unilateral 
nephrectomy or 40% resection of the small bowel were 
treated as described above for the 40% hepatectomized 
rats. 
[lHJThymidine incorporation and mitotic index deter-
minations were made as described previously (9. 12). An 
augmentation of all parameters. beyond the modest re-
sponse that is present after sham surgery, was considered 
to be indicative of biologic activity of the liver extracts. 
In dogs, the active electrophoretic fraction. Acr-F4 was 
infused in the left hepatic lobes through the left portal 
branch as described in Table 2. At the time of sacrifice. 
liver tissue was obtained from the left and right hepatic 
lobes and shunt patency and catheter position were 
verified. The labeling index was determined as described 
earlier (9). 
TABLE l. PRE PARA TlON OF HSS 
Purification sr,'ps 
I. Remove the liver. Immediately after killing by gUIllotine. between 7:00 and 8:00 AM 
2. Mince and then homogenize the liver in 150 mM sodium acetate buffer. pH 4.65 (35:100 w/v) 
3. Ultracentnfuge homogenate at 24.000 f? for 30 min at 4' C 
4. Heat at b5° C for 15 min 
5. Centrifuge at 30.000 II for 20 min at 4° C. collect supernatant and add to it 6 vol of cold 
ethanol (I :6. viv) 
6. Stir at .:!-Ro C for 2 hr 
7. Centnfuge 30.000 l! for 20 min at 4' C 
~K Resuspend preClpltale In 0.150 mM ammonium acetate. pH = 6 
9. Filter OH·F through an Amlcon membrane with a molecular weight cutoff of 30.000 Oa 
10. Collect the filtrate and concentrate It by a 500-0a cutolf Amlcon membrane 
II. Lyophlille 30 kDa-F 
12. Resuspend lyophilized 30 kDa·F in phosphate buffer S mM. pH 6. and perform 
chromato~raphy uSing mono Q HR 5/5 column With a linear 0-200 mM NaCI gradu::nt 10 
phosphate bUlfer 
13. Collect the chromatographic peak at 150 mM NaCi gradient 
ai~tllll·t DiltQltl and pCl~nCtDlK ~·o/K 36. So. j (Mov /99/1 
Product 
Cytosol fraction (Cyt·F) 
Alcohol fraction tOB·F) 
Mr 30.000 fraction (.\0 kOa·F) 
150 fraction (F I <0) 
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TABLE:!. PROTOCOL FOR Acr·F. INFUSION AND 'k OF LABELED NUClEI DETERMINATION IN ECK FISTULA DOGS 
Beginning of infusion 
Duration of infusion 
6 hr after surgery 
"* days 
Infused material 
Volume mfused 
Acr·F. (50 nglkg body wt/day) in saline solution containing NH. acetate 5 mM and bovine 
serum albumm 0.5 mgllOO ml 
25 mliday 
Treatment for labelling nuclei 200 ~Ci of [)Hlthymidine HC.:! Ci/mmoll/kg body wt injected IV two hours before killing 
Determination of DNA Synthesis in Organs Other Than 
Liver. DNA synthesis in kidney and small intestine was 
determined as described previously (8). 
Analyses of Physical and Chemical Properties. F ISO and 
Acr-F 4 were tested for trypsin and chymotrypsin sensi· 
tivity (13). heat stability. and neuroaminidase sensitivity 
( 14). 
SDS·PAGE. SDS·polyacrylamide gradient slab gel. us· 
ing 7.5-20% gel with a 5% stacking gel. was prepared and 
developed according to the method of Laemmli (15). Both 
cf~o and Acr·F4 undergo electrophoresis under these 
conditions. Protein bands were visualized using 
Coomassie blue R250 according to the method of Weber 
and Osborn (16l. 
!\fonoclonal Antibody (Ab). Murine monoclonal anti-
bodies against Acr·F. were raised using PHC 43 and PHC 
67 cells (17). The cells were cultured in serum-free 
medium and the monoclonal Abs were separated by 
protein·A chromatography. Activity was assessed by 
ELISA and found to be in the IgG fraction. 
Protein Determination. Protein content was deter-
mined by the method of Lowry et al (18). Submicrogram 
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quantities were measured using the method of McK. 
night (19). 
Statistical Analysis. The unpaired Student's t test was 
used for the statistical analysis of all data. 
RESULTS 
In earlier investigations (6). the greatest degree of 
purification of HSS was obtained using fast protein 
liquid chromatography. By this technique. F 150 
(Figure 2). which was the most active fraction in 
40% hepatectomized rats. was prepared. The use of 
nondissociating PAGE made it possible to further 
purify F I50 (Figure 3). 
The activity of F'5o and its PAGE fractions were 
compared using 40% hepatectomized rats (Figure 
4). The administration of cI~o (3 ~g/ratF produced 
results as previously reported (6). When fractions of 
Acr F1 
...... 
Fill 3. Nonolssocl3l1ng PAGE of F,.o. For our nondissoCI311ng 
continuous svstem. we IJsc=d Tris Hel 0.375 M as resolvm~ gel 
butfer and Tris HCI lKl~R M + ~fvelnc= 0.192 ~t as reservoir 
huffer. The aerylamlde gel concc~t;atlon was 11%. The matenal 
used for thiS run was oblalned as pool of Icn F I~o· 
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Fig 4. Effect of cI~o and PAGE fractions CAcr-FI-F.) on DNA 
synthesis in 40% hepatectomized rats. The experimental condi-
tions are described in Materials and Methods. The values ex-
pressed by the bars are averages:!: so from no less than 15 rats. 
All HSS fraction were dissolved in 2 ml PBS at the following 
concentrations: F"o 1.5 ILg/ml: Acr-F, 0.05 l1g/ml: and Aer-
c~-cK 0.15 ILgJml. 'P < 0.01 versus control. 
Acr F I-F 4 were tested. the only fraction with stim-
ulatory activity similar to that of Flso was found in 
Acr-F4 • 
The results shown in Figure 5 demonstrate a 
dose-effect relation between the amount of Acr-F 4 
injected and the resultant increase in hepatocyte 
DNA synthesis and the number of mitoses enumer-
ated. In addition. with the highest dose of Acr-Fo$ 
(0.6 fLgllOO g body wO. the activity achieved was 
fivefold greater than the background response in 
control animals. 
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Fig 6. ()H1Thymidine incorporation in kidney and small intestine 
from normal rats and Acr F.-treated or untreated rats with 
unilateral nephrectomy or 40% resected small intestine. The 
values represented by the different bars (0 controls. _ 
unilateral nephrectomy. Ell Acr F. treatment + unilateral ne-
phrectomy. 0 panial enterectomy. iii Acr F. treatment + panial 
enterectomy). arc the means:!: so from 10 rats. 
To evaluate the organ specificity of Acr-F4 • rats 
with either a unilateral nephrectomy or a 40% 
resection of the small bowel were tested. No in-
crease in DNA synthesis was found in the contra-
lateral residual kidney or in the remaining small 
intestine (Figure 6). 
The experiments performed in dogs demonstrate 
that when Acr-Fo$ was administered as a continuous 
infusion beginning 6 hr after portacaval shunt in the 
left portal vein. the mitotic rate tripled in the left 
liver lobe while no effect was seen in the right side 
of the liver. This effect was completely eliminated 
with the addition of anti-Acr-F4 monoclonal anti-
body to the infusion fluid (Table 3). The monoclonal 
antibody vehicle was inert when tested alone. 
Table 4 summarizes the physicochemical charac-
teristics of Acr-F4 • It contains one major protein 
band with a molecular weight of about 14.000 (Fig-
TABLE 3. EFFECT IN DOGS OF LEFT PORTAl. BRANCH 
INFUSION FOR 4 DAYS OF Acr·F •. BEGINNING b IIR AHFR 
PORTACAVAL SHUNT 
Vehicle 
Acr-F. 
SlIbSfanCt' 
Acr-F ... Monoclonal AbO 
No. 
Lllbt'lt'tI nllc/t·j! 
/()OO it,'ptllllC\·f,',1 
<.Immals Ril!itf lohe L<'/i lohe 
4.4 :!: 0.11 
4.4 ~ ffK~ 
4.1 = ffK~ 
4.11 1: 0.4 
I ~K~ !: I.ot 
·U 1: 0.3 
.:\ mixlure of active I!!U(s I. addtn!! up III I ~l I1g ,If protein d;lI)v. 
was added to the veh.c1e containing A.:r· F. and Incubated I'M .2 
hr at 37 "C before InluslOn. 
tSignilicantly dillerent from control (/' < 11.001 ~untp •• rcd to all 
other groups). 
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Fig 7. SDS-PAGE of F'50 and Acr-F •. The gel preparation is 
described in Materials and Methods. Lanes 1 and 4 = standard 
mixture (molecular weights are multiplied by 10-3); slot 2 = 
Acr-F,; slot 3 = F'5o. 
ure 7). Experiments conducted in 40% hepatecto-
mized rats demonstrated that Acr-F4 is heat-
resistant and is not digested by neuroaminidase, 
whereas it is sensitive to proteolitic enzymes (data 
not shown). 
DISCUSSION 
The idea of a specific intrinsic liver growth factor 
was conceived almost 40 years ago when Teir and 
Ravanti (20) and Blomqvist (21) first reported a 
growth stimulatory activity in crude mesh extracts 
of weanling and regenerating rat liver but not in 
extracts from normal adult rat liver. Since then, a 
large number of studies (1-6) have suggested that 
regenerating liver is a source of a growth stimulator 
which is specific for the liver (Table 5). 
Among the substances proposed and studied. 
HSS has been studied most extensively by LaBrec-
que and coworkers (I, 2), Starzl et al (3), and 
Francavilla et al (5, 6). 
Data reported previously (6) and the new data in 
this paper regarding Acr-F4 are summarized in 
Table 6. A 381,OOO-fold increase in activity over the 
original material was achieved using the 40% hepa-
tectomized rat model as the test system. The activ-
ity present in this fraction EAcr-c~F is not species-
specific, as demonstrated by the results obtained in 
dogs as well as rats and produced a dose-response 
that was specific for the liver (Figure ()). 
The HSS found in weanling rat liver also has a 
powerful regenerating or growth effect on dog liver 
as assessed by the Eck fistula model. The degree of 
stimulation achieved with 50 ng;kg;day was as po-
tent as gram quantities of crude cytosol (3, 4) and 
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was as pronounced as the most potent well. 
recognized hepatotrophic substance currently avail-
able: insulin (9). In common with insulin (9) and 
crude cytosol (4), purified HSS affects only the 
directly infused liver tissue with little spillover to 
the uninfused liver. This suggests that it is largely 
degraded or consumed within a single pass through 
the liver, leaving little or none available to effect the 
contralateral hepatic lobes_ 
In an earlier report (6), it was shown that HSS 
prepared under these conditions loses its in vitro 
activity while retaining its in vivo activity. Thus it 
has not been possible to compare the HSS purified 
by LaBrecque et al (22) and Fleig and Hoss (23), 
which remained active in vitro with Acr-F4 • The 
explanation for the disparities between in vivo and 
in vitro growth stimulation seen with Acr-F4 and 
these other fractions will not be resolvable until 
these substances are known. 
[n conclusion, the retention of in vivo activity of 
a highly purified HSS fraction, the ability to abolish 
the stimulatory activity of this fraction with specific 
monoclonal antibodies, and the organ specificity of 
Acr-F4 suggests that its complete identification 
should be close at hand. 
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